Translational Development Acquisition Corp.

$10.49

+$0.00 (+0.00%)

Jan 5, 2026

Price History (1Y)

Analysis

Translational Development Acquisition Corp. is a company listed in the Financial Services sector within the Shell Companies industry, with a market capitalization of $229.81 million. The financials for Translational Development Acquisition Corp. show net income of $4.76 million over the trailing twelve months. However, the company has negative free cash flow at -$588,485 and minimal gross margin, operating margin, and profit margin of 0.0% each. The balance sheet indicates that the company has a current ratio of 0.19, debt of $100,000, and $47,150 in cash. The valuation context for Translational Development Acquisition Corp. shows a P/E ratio of 47.68 over the trailing twelve months, with a price to book value of -36.05.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Translational Development Acquisition Corp.

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Visit website →

Key Statistics

Market Cap
$229.81M
P/E Ratio
47.68
52-Week High
$10.49
52-Week Low
$10.00
Avg Volume
5.95K

Company Info

Exchange
NGM
Country
United States